Virtu Financial LLC Sells 3,503 Shares of Medidata Solutions Inc (NASDAQ:MDSO)

Virtu Financial LLC cut its position in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 47.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,813 shares of the company’s stock after selling 3,503 shares during the period. Virtu Financial LLC’s holdings in Medidata Solutions were worth $257,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MDSO. Vanguard Group Inc. increased its holdings in Medidata Solutions by 2.8% in the third quarter. Vanguard Group Inc. now owns 5,200,744 shares of the company’s stock valued at $381,266,000 after purchasing an additional 142,687 shares during the last quarter. Vanguard Group Inc increased its holdings in shares of Medidata Solutions by 2.8% in the third quarter. Vanguard Group Inc now owns 5,200,744 shares of the company’s stock worth $381,266,000 after acquiring an additional 142,687 shares in the last quarter. Clearbridge Investments LLC increased its holdings in shares of Medidata Solutions by 5.9% in the third quarter. Clearbridge Investments LLC now owns 2,429,627 shares of the company’s stock worth $178,116,000 after acquiring an additional 135,078 shares in the last quarter. Pictet Asset Management Ltd. increased its holdings in shares of Medidata Solutions by 7.7% in the third quarter. Pictet Asset Management Ltd. now owns 1,626,688 shares of the company’s stock worth $119,252,000 after acquiring an additional 115,641 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of Medidata Solutions by 6.5% in the third quarter. American Century Companies Inc. now owns 1,592,367 shares of the company’s stock worth $116,736,000 after acquiring an additional 97,571 shares in the last quarter.

MDSO opened at $72.05 on Thursday. The company has a market capitalization of $4.48 billion, a PE ratio of 84.76, a price-to-earnings-growth ratio of 4.23 and a beta of 1.32. The company has a quick ratio of 2.52, a current ratio of 2.52 and a debt-to-equity ratio of 0.15. Medidata Solutions Inc has a 12-month low of $60.10 and a 12-month high of $88.87.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Tuesday, February 12th. The company reported $0.45 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.08. The business had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $168.08 million. Medidata Solutions had a return on equity of 10.70% and a net margin of 8.43%. The firm’s revenue for the quarter was up 18.1% compared to the same quarter last year. During the same period last year, the firm posted $0.41 EPS. As a group, equities research analysts anticipate that Medidata Solutions Inc will post 0.85 earnings per share for the current fiscal year.

In other news, EVP Michael Pray sold 7,000 shares of Medidata Solutions stock in a transaction on Monday, November 26th. The stock was sold at an average price of $73.02, for a total value of $511,140.00. Following the transaction, the executive vice president now owns 52,408 shares in the company, valued at approximately $3,826,832.16. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Rouven Bergmann sold 10,000 shares of Medidata Solutions stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $79.00, for a total value of $790,000.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 41,632 shares of company stock worth $3,126,704. Corporate insiders own 4.70% of the company’s stock.

MDSO has been the subject of several recent analyst reports. Piper Jaffray Companies lowered their price target on Medidata Solutions from $96.00 to $93.00 in a report on Thursday, October 18th. Zacks Investment Research upgraded Medidata Solutions from a “hold” rating to a “buy” rating and set a $76.00 price target for the company in a report on Monday, January 21st. Royal Bank of Canada set a $86.00 price objective on Medidata Solutions and gave the stock a “buy” rating in a report on Friday, October 19th. ValuEngine upgraded Medidata Solutions from a “hold” rating to a “buy” rating in a report on Thursday, November 1st. Finally, BidaskClub upgraded Medidata Solutions from a “hold” rating to a “buy” rating in a report on Wednesday, January 30th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $83.64.

COPYRIGHT VIOLATION NOTICE: “Virtu Financial LLC Sells 3,503 Shares of Medidata Solutions Inc (NASDAQ:MDSO)” was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/02/14/virtu-financial-llc-has-257000-stake-in-medidata-solutions-inc-mdso.html.

Medidata Solutions Company Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Featured Story: What is Considered a Good Return on Equity (ROE)?

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply